Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid Cells
- 10 January 2008
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 82 (1), 113-124
- https://doi.org/10.1016/j.ajhg.2007.09.007
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyriaBlood, 2006
- Uroporphyrinogen III Synthase Knock-In Mice Have the Human Congenital Erythropoietic Porphyria Phenotype, Including the Characteristic Light-Induced Cutaneous LesionsAmerican Journal of Human Genetics, 2006
- Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease)European Journal of Pediatrics, 2004
- Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selectionGene Therapy, 2004
- Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without PreselectionMolecular Therapy, 2001
- Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cellsGene Therapy, 2001
- Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literatureBone Marrow Transplantation, 2001
- Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphyriaHepatology, 2000
- Congenital erythropoietic porphyriaJournal of the American Academy of Dermatology, 1997
- Correction of congenital erythropoietic porphyria by bone marrow transplantationThe Journal of Pediatrics, 1996